Peptide-Vehicle Library



Overview

In the three years from FY 2008 to FY 2010, we promoted Okinawa Innovation Research Consignment Project “Developing cancer therapeutic drugs and test methods using peptide libraries”. We designed a peptide-vehicle in which a cell surface recognition peptide, a cell penetrating peptide and an anticancer agent are conjugated as a candidate substance for “cell targeting therapeutic drug”, and studied to construct a library. We will provide “Peptide-Vehicle Library” constructed based on the results. In recent years, problems such as QOL decrease due to side effects, patent disappearance of anticancer substances are a problem, and it is expected that drugs will be delivered that anticancer drugs specifically to cancer cells. We hope to use it as a tool of drug discovery research.

Reference Hirata, A., Nokihara, K. Construction of peptide-vehicles, bioconjugates having modules of cancer cell surface capture and cell-penetrating peptide with anticancer agents, Tetrahedron Lett. 2014, 55, 4091-4094.

Peptide No. Sequence(C terminal amide)
HiPeV-001F αTAMRA-GPKSKRKVYGRKKRRQRRR
HiPeV-002F αTAMRA-GPKSKRKVRQIKIYFQNRRMKWKK
HiPeV-003F αTAMRA-GPKSKRKVRRRRRRRRR
HiPeV-004F αTAMRA-GPKSKRKVRRRRNRTRRNRRRVR
HiPeV-005F αTAMRA-GKKNQKKRYGRKKRRQRRR
HiPeV-006F αTAMRA-GKKNQKKRRQIKIYFQNRRMKWKK
HiPeV-007F αTAMRA-GKKNQKKRRRRRRRRRR
HiPeV-008F αTAMRA-GKKNQKKRRRRRNRTRRNRRRVR
HiPeV-009F αTAMRA-GPKSKRKV
HiPeV-010F αTAMRA-GKKNQKKR
HiPeV-011F αTAMRA-GYGRKKRRQRRR
HiPeV-012F αTAMRA-GRQIKIYFQNRRMKWKK
HiPeV-013F αTAMRA-GRRRRRRRRR
HiPeV-014F αTAMRA-GRRRRNRTRRNRRRVR
HiPeV-015F TAMRA-G-YKQC(Acm)HKKGGKKGSG
HiPeV-016F TAMRA-cNGRGEQcYGRKKRRQRRR
HiPeV-017F TAMRA-cNGRGEQcRQIKIYFQNRRMKWKK
HiPeV-018F TAMRA-cNGRGEQcRRRRRRRRR
HiPeV-019F TAMRA-cNGRGEQcRRRRNRTRRNRRRVR
HiPeV-020F TAMRA-YGRKKRRQRRRcNGRGEQc
HiPeV-021F TAMRA-RQIKIYFQNRRMKWKKcNGRGEQc
HiPeV-022F TAMRA-RRRRRRRRRcNGRGEQc
HiPeV-023F TAMRA-RRRRNRTRRNRRRVRcNGRGEQc
HiPeV-024F FAM-GYGRKKRRQRRR
HiPeV-025F FAM-GRQIKIYFQNRRMKWKK
HiPeV-026F FAM-GRRRRRRRRR
HiPeV-001D C(S-EMCA-Gly-CPT)-YGRKKRRQRRR
HiPeV-002D C(S-EMCA-Gly-Iri)-YGRKKRRQRRR
HiPeV-003D C(S-EMCA-Gly-Eto)-YGRKKRRQRRR
HiPeV-004D C(S-EMCA-Gly-Pac)-YGRKKRRQRRR
Peptide No. Sequence(C terminal amide)
HiPeV-005D Cys(S-EMCA-Gly-CPT)-YGRKKRRQRRRcNGRGEQc
HiPeV-006D Cys(S-EMCA-Gly-Iri)-YGRKKRRQRRRcNGRGEQc
HiPeV-007D Cys(S-EMCA-Gly-Eto)-YGRKKRRQRRRcNGRGEQc
HiPeV-008D Cys(S-EMCA-Gly-Pac)-YGRKKRRQRRRcNGRGEQc
HiPeV-009D Cys(S-EMCA-Gly-CPT)-RQIKIYFQNRRMKWKKcNGRGEQc
HiPeV-010D Cys(S-EMCA-Gly-Iri)-RQIKIYFQNRRMKWKKcNGRGEQc
HiPeV-011D Cys(S-EMCA-Gly-Eto)-RQIKIYFQNRRMKWKKcNGRGEQc
HiPeV-012D Cys(S-EMCA-Gly-Pac)-RQIKIYFQNRRMKWKKcNGRGEQc
HiPeV-013D Cys(S-EMCA-Gly-CPT)-RRRRRRRRRcNGRGEQc
HiPeV-014D Cys(S-EMCA-Gly-Iri)-RRRRRRRRR cNGRGEQc
HiPeV-015D Cys(S-EMCA-Gly-Eto)-RRRRRRRRRcNGRGEQc
HiPeV-016D Cys(S-EMCA-Gly-Pac)-RRRRRRRRRcNGRGEQc
HiPeV-017D Cys(S-EMCA-Gly-CPT)-RRRRNRTRRNRRRVRcNGRGEQc
HiPeV-018D Cys(S-EMCA-Gly-Iri)-RRRRNRTRRNRRRVRcNGRGEQc
HiPeV-019D Cys(S-EMCA-Gly-Eto)-RRRRNRTRRNRRRVRcNGRGEQc
HiPeV-020D Cys(S-EMCA-Gly-Pac)-RRRRNRTRRNRRRVRcNGRGEQc
Copied title and URL